#StudyGraphics: Adjuvant abemaciclib improves survival in patients with hormone receptor-positive early breast cancer
Click to read this study in The Lancet Oncology.
Tag: abemaciclib
Letrozole and abemaciclib in estrogen receptor–positive recurrent endometrial cancer
1. Almost half of patients (47%) had either an objective response or had progression free survival for at least 6 ...
Abemaciclib linked to disease control in patients with p16ink4A-negative mesothelioma
1. Disease control was reported in over half of the patients treated with abemaciclib 2. Most common adverse events included ...
